Position in HLN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,869,209
+$1,422,850 QoQ
Shares Held
200,344
+374.9% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#112
of 639 holders
Holding Since
Sep 2022
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Engineers Gate Manager LP holds $33,272,501 across 27 Drug Manufacturers - Specialty & Generic names. HLN ranks #6 (5.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
107,678 | $7,737,741 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
18,361 | $3,094,562 | |
| 3 | LQDA |
Liquidia Corp
|
36,213 | $2,887,262 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
4,658 | $2,523,844 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
83,722 | $2,060,398 | |
| 6 | HLN |
Haleon plc
This page
|
200,344 | $1,869,209 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
|
175,002 | $1,750,020 | |
| 8 | PAHC |
Phibro Animal Health Corp
|
52,914 | $1,661,499 |
All Filings in HLN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,869,209 | 200,344 | Shares | Sole | 2026-08-14 | |
| 2024-09-30 | $446,359 | 42,189 | Shares | Sole | 2024-11-14 | |
| 2022-09-30 | $92,677 | 15,218 | Shares | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||